Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rotmensz

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
Breast Cancer Research and Treatment|January 23, 2008
Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institutionJ Y Petit, O Gentilini, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2006
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesU Veronesi, C De Cicco, V E Galimberti, et al.
Breast Cancer Research and Treatment|November 9, 2011
Prognostic role of CA15.3 in 7942 patients with operable breast cancerM T Sandri, M Salvatici, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcomeE Botteri, N Rotmensz, C Sangalli, et al.
Breast Cancer Research and Treatment|April 27, 2012
Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institutionE Botteri, O Gentilini, N Rotmensz, et al.
The Pharmacogenomics Journal|March 24, 2010
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention TrialD Serrano, M Lazzeroni, C-F Zambon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2005
Breast cancer diagnosed during pregnancy and lactation: biological features and treatment optionsO Gentilini, M Masullo, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2011
Locoregional recurrence risk after lipofilling in breast cancer patientsJ Y Petit, E Botteri, V Lohsiriwat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni, N Rotmensz, G Peruzzotti, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
Breast Cancer Research and Treatment|January 23, 2008
Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institutionJ Y Petit, O Gentilini, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2006
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesU Veronesi, C De Cicco, V E Galimberti, et al.
Breast Cancer Research and Treatment|November 9, 2011
Prognostic role of CA15.3 in 7942 patients with operable breast cancerM T Sandri, M Salvatici, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcomeE Botteri, N Rotmensz, C Sangalli, et al.
Breast Cancer Research and Treatment|April 27, 2012
Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institutionE Botteri, O Gentilini, N Rotmensz, et al.
The Pharmacogenomics Journal|March 24, 2010
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention TrialD Serrano, M Lazzeroni, C-F Zambon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2005
Breast cancer diagnosed during pregnancy and lactation: biological features and treatment optionsO Gentilini, M Masullo, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2011
Locoregional recurrence risk after lipofilling in breast cancer patientsJ Y Petit, E Botteri, V Lohsiriwat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni, N Rotmensz, G Peruzzotti, et al.
Pageof 10